Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-09-05
2006-09-05
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S445000, C549S062000, C549S078000
Reexamination Certificate
active
07101904
ABSTRACT:
A compoundor a pharmaceutically acceptable salt or a prodrug thereof, wherein A, B, R1, R2, D, and E are defined herein. Use of the diseases for the treatment of diseases, and compositions and medicaments related thereto are also disclosed.
REFERENCES:
patent: 4119727 (1978-10-01), Buendia et al.
patent: 4166452 (1979-09-01), Generales et al.
patent: 4256108 (1981-03-01), Theeuwes
patent: 4265874 (1981-05-01), Bonsen et al.
patent: 4994274 (1991-02-01), Chan et al.
patent: 5028624 (1991-07-01), Chan et al.
patent: 5034413 (1991-07-01), Chan et al.
patent: 5385945 (1995-01-01), Garst et al.
patent: 5446041 (1995-08-01), Chan et al.
patent: 5599838 (1997-02-01), Sato et al.
patent: 5688819 (1997-11-01), Woodward et al.
patent: 5741810 (1998-04-01), Burk
patent: 5834498 (1998-11-01), Burk
patent: 5972991 (1999-10-01), Burk
patent: 6124344 (2000-09-01), Burk
patent: 6248773 (2001-06-01), Burk
patent: 6376533 (2002-04-01), Burk et al.
patent: 6586462 (2003-07-01), Burk et al.
patent: 6680337 (2004-01-01), Burk
patent: 2002/0094981 (2002-07-01), Ponticello et al.
patent: WO 99/25358 (1999-05-01), None
patent: WO 02/100388 (2002-12-01), None
patent: WO 03/002755 (2003-01-01), None
Bito, L.Z.Biological Protection with Prostaglandins, Cohen, M.M., ed., Boca Raton, Fla, CRC Press Inc., 1985, pp. 231-252.
Bito, L.Z.,Applied Pharmacology in the Medical Treatment of GlaucomasDrance, S.M. and Neufeld, A.H. eds., New York, Grune & Stratton, 1984, pp. 477-505.
Bito, L.Z.,Arch. Ophthalmol. 105,1036 (1987).
Francis A. Carey, Organic Chemistry, New York: McGraw-Hill Book Company 1987, p. 63.
Nilsson et. al.,Invest. Ophthalmol. Vis. Sci.(suppl), 284 (1987).
Remington's Pharmaceutical Sciences, Mack Publishing Company, Easton, Pa., 16th Edition, 1980.
Siebold et al.,Esterified Prostaglandin Shows ‘Potent’ Promise,Ocular Surgery News, vol. 1, No. 3 (Feb. 1989); pp. 3, 59.
Burk Robert M.
Donde Yariv
Garst Michael E.
Allergan Inc.
Baran Robert J.
Grazier Nyeemah
Johnson Brent A.
Saeed Kamal A.
LandOfFree
Cyclopentane heptan(ENE)OIC acid, 2-heteroarylalkenyl... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cyclopentane heptan(ENE)OIC acid, 2-heteroarylalkenyl..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclopentane heptan(ENE)OIC acid, 2-heteroarylalkenyl... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3576781